| ||
| NSCLC trial stopped due to safety concerns HemOncToday ... have stopped enrollment in one of their two global studies evaluating necitumumab as a first-line treatment for advanced non–small cell lung cancer. ... See all stories on this topic » | ||
| Hormone therapy and menopause Sun-Sentinel Other recent studies have looked at hormone therapy and lung cancer, and the impact of hormone therapy on mortality. In this web chat, we talk to a leading ... See all stories on this topic » |
| ||
| Estrogen blockage reduces risk of dying from lung cancer ... Previous research suggests that menopausal hormone therapy increases women's risk of dying from lung cancer. "If prospective studies confirm our results and ... www.eurobiotechnews.eu/central.../articledetail/?tx...5... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment